The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Seyedkazemi Setareh since 2022.
This trader's CIK number is 1903088.
At the time of last reporting, Seyedkazemi Setareh was the Chief Development Officer of Adverum Biotechnologies, Inc.. (stock ticker symbol ADVM).
Also see all insider trading activities at Adverum Biotechnologies, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | ADVM | 0 | $0 | 6,201 | $9,512 | 0 | $0 |
| 2022 | ADVM | 20,000 | $16,800 | 6,058 | $6,482 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-09-15 | ADVM | Sale | 6,201 | 1.53 | 9,512 |
| 2022-09-19 | ADVM | Sale | 6,058 | 1.07 | 6,482 |
| 2022-05-23 | ADVM | Buy | 20,000 | .84 | 16,800 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Seyedkazemi Setareh (Chief Development Officer of Adverum Biotechnologies, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.